Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma

dc.contributor.authorLi, Qing K.
dc.contributor.authorHu, Yingwei
dc.contributor.authorChen, Lijun
dc.contributor.authorSchnaubelt, Michael
dc.contributor.authorCui Zhou, Daniel
dc.contributor.authorLi, Yize
dc.contributor.authorLu, Rita Jui-Hsien
dc.contributor.authorThiagarajan, Mathangi
dc.contributor.authorHostetter, Galen
dc.contributor.authorNewton, Chelsea J.
dc.contributor.authorJewell, Scott D.
dc.contributor.authorOmenn, Gil
dc.contributor.authorRobles, Ana I.
dc.contributor.authorMesri, Mehdi
dc.contributor.authorBathe, Oliver F.
dc.contributor.authorZhang, Bing
dc.contributor.authorDing, Li
dc.contributor.authorHruban, Ralph H.
dc.contributor.authorChan, Daniel W.
dc.contributor.authorZhang, Hui
dc.date.accessioned2022-10-23T00:03:18Z
dc.date.available2022-10-23T00:03:18Z
dc.date.issued2022-10-20
dc.date.updated2022-10-23T00:03:18Z
dc.description.abstractAbstract Background The identification of differentially expressed tumor-associated proteins and genomic alterations driving neoplasia is critical in the development of clinical assays to detect cancers and forms the foundation for understanding cancer biology. One of the challenges in the analysis of pancreatic ductal adenocarcinoma (PDAC) is the low neoplastic cellularity and heterogeneous composition of bulk tumors. To enrich neoplastic cells from bulk tumor tissue, coring, and laser microdissection (LMD) sampling techniques have been employed. In this study, we assessed the protein and KRAS mutation changes associated with samples obtained by these enrichment techniques and evaluated the fraction of neoplastic cells in PDAC for proteomic and genomic analyses. Methods Three fresh frozen PDAC tumors and their tumor-matched normal adjacent tissues (NATs) were obtained from three sampling techniques using bulk, coring, and LMD; and analyzed by TMT-based quantitative proteomics. The protein profiles and characterizations of differentially expressed proteins in three sampling groups were determined. These three PDACs and samples of five additional PDACs obtained by the same three sampling techniques were also subjected to genomic analysis to characterize KRAS mutations. Results The neoplastic cellularity of eight PDACs ranged from less than 10% to over 80% based on morphological review. Distinctive proteomic patterns and abundances of certain tumor-associated proteins were revealed when comparing the tumors and NATs by different sampling techniques. Coring and bulk tissues had comparable proteome profiles, while LMD samples had the most distinct proteome composition compared to bulk tissues. Further genomic analysis of bulk, cored, or LMD samples demonstrated that KRAS mutations were significantly enriched in LMD samples while coring was less effective in enriching for KRAS mutations when bulk tissues contained a relatively low neoplastic cellularity. Conclusions In addition to bulk tissues, samples from LMD and coring techniques can be used for proteogenomic studies. The greatest enrichment of neoplastic cellularity is obtained with the LMD technique.
dc.identifier.citationClinical Proteomics. 2022 Oct 20;19(1):36
dc.identifier.doihttps://doi.org/10.1186/s12014-022-09373-x
dc.identifier.urihttp://hdl.handle.net/1880/115372
dc.language.rfc3066en
dc.rights.holderThe Author(s)
dc.titleNeoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
12014_2022_Article_9373.pdf
Size:
3.02 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description: